SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 63 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,575,000 | +44.2% | 2,929,195 | -0.5% | 0.33% | +34.0% |
Q2 2022 | $12,189,000 | +14.8% | 2,944,255 | +5.3% | 0.24% | +59.5% |
Q1 2022 | $10,622,000 | +33.4% | 2,795,209 | +57.9% | 0.15% | +39.1% |
Q4 2021 | $7,963,000 | -0.4% | 1,769,854 | +3.1% | 0.11% | +2.8% |
Q3 2021 | $7,998,000 | -28.4% | 1,716,067 | +8.3% | 0.11% | -34.8% |
Q2 2021 | $11,166,000 | +53.3% | 1,583,889 | +28.5% | 0.16% | +62.4% |
Q1 2021 | $7,283,000 | – | 1,232,394 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,431,705 | $14,371,000 | 5.72% |
Ghost Tree Capital, LLC | 904,225 | $5,136,000 | 1.21% |
RA Capital Management | 5,914,252 | $34,953,000 | 0.53% |
NEA Management Company, LLC | 2,997,682 | $17,716,000 | 0.40% |
Vivo Capital, LLC | 1,232,394 | $7,283,000 | 0.26% |
Monashee Investment Management LLC | 176,057 | $1,040,000 | 0.16% |
Ikarian Capital, LLC | 676,294 | $3,997,000 | 0.14% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $11,146,000 | 0.13% |
SAMLYN CAPITAL, LLC | 1,232,394 | $7,283,000 | 0.10% |
Maven Securities LTD | 173,029 | $1,026,000 | 0.05% |